IL-4-induced apoptosis in peripheral blood eosinophils.
BACKGROUND
The regulation of eosinophil survival and apoptosis may play a major role in diseases demonstrating increased numbers of circulating and tissue eosinophils such as allergic reactions. Because few promoters of eosinophil apoptosis have been described so far, the objective of this study was to elucidate the role of endogenous factors on eosinophil survival and apoptosis.


RESULTS
Highly purified peripheral blood eosinophils were analyzed in the time course from 24 up to 144 hours in culture. Eosinophil survival was assessed with trypan blue dye exclusion and apoptosis was determined by DNA fragmentation gel analysis and ELISA technique with anti-histone antibodies. We confirmed previous results demonstrating prolonged eosinophil survival and inhibited apoptosis by IL-3, IL-5, and GM-CSF. In contrast, eosinophil apoptosis was significantly enhanced by corticosteroids, particularly dexamethasone and hydrocortisone. However, IL-1beta, IL-8, IL-12, platelet-activating factor, TNF-alpha, and eotaxin had no effect on eosinophil survival or apoptosis when compared with culture medium alone. In contrast, IL-4 at concentrations of 100 U/mL or more inhibited eosinophil survival and induced apoptosis. This effect was time dependent and abrogated by preincubation with neutralizing anti-IL-4 antibodies. However, after 96 hours in coincubation, IL-4 did overcome the survival-prolonging effect of IL-3, IL-5, and GM-CSF. IL-4 did not enhance eosinophil surface expression of APO-1/Fas antigen (CD95). In assessing IL-4-mediated effects on eosinophil function, we found no response by means of the release of eosinophil cationic protein or reactive oxygen species.


CONCLUSIONS
Taken together, our data present direct evidence for the presence of functional IL-4 receptors on human eosinophils and indicate that IL-4 may lead to resolution of chronic inflammation by induction of eosinophil apoptosis.
Wedi
B
B
Department of Dermatology and Allergology, Hannover Medical University, Germany.
Raap
U
U
Lewrick
H
H
Kapp
A
A
D017209:Apoptosis / Q000276:immunology*; D001798:Blood Proteins / Q000378:metabolism; D002462:Cell Membrane / Q000276:immunology; D002470:Cell Survival / Q000276:immunology; D002478:Cells, Cultured; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000276:immunology*; D006801:Humans; D015847:Interleukin-4 / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000378:metabolism; D012260:Ribonucleases; D019014:fas Receptor / Q000096:biosynthesis
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D017382:Reactive Oxygen Species; D019014:fas Receptor; D015847:Interleukin-4; D012260:Ribonucleases